Abstract:Background The majority of autoimmune diseases, e.g. rheumatoid arthritis (RA), are characterized by autoantibodies that are produced by B cells. We have identified several novel post-translationally modified epitopes in collagen type II (CII), a major cartilage constituent that are autoreactive. In mouse models, autoantibodies that bind to these epitopes can either induce or protect against inflammatory arthritis. However, very little is known about the frequencies or phenotype the B cells that produce these autoantibodies in humans. Objectives The aim of this project is to study the B cells that produce autoantibodies reactive to CII-epitopes in patients with RA. Methods Clinical data and peripheral blood were collected from patients with RA (n=100). Titres of CII-reactive serum-autoantibodies were determined by Luminex. The different subsets of B cells that expressed a CII-reactive B cell receptor (BCR) were analysed and isolated in patients with positive (n=10) or negative (n=5) titres for autoantibodies recognizing the CII-epitopes cyc48 (CII-F4-R-Cit) and cyc49 (CII-F4-Cit-R) as well as in healthy controls (n=3) using flow cytometry. Results In patients with detectable autoantibodies to cyc48 and cyc49, their titres were 13761±3815 and 5585±1992 (mean ± SEM), respectively. The corresponding titres in the patients negative for these autoantibodies were 122±55 and 234±75. In autoantibody-positive patients, the frequencies of cells expressing a BCR reactive for cyc48 and cyc49 in different subsets were: transitional cells 0.88±0.18% and 1.33±0.33%; naïve cells 0.09±0.0008% and 0.13±0.06 and memory cells 0.31±0.25 and 0.30±0.12%. All frequencies were well above those detected in patients without cyc48/49 titres and in healthy controls. A higher proportion (p=0.03) of the cyc48/49 positive patients were treated with methotrexate compared to cyc48/49 negative patients, no other clinical differences were recorded. CII-reactive single B cells were isolated in order to clone the BCR Conclusions In patients with manifest RA there is a relatively high and detectable frequency of transitional B cells that express a joint-specific BCR, which suggests that the deletion of autoreactive B cells in the bone marrow in RA patients is defective. As there is a decrease in the proportion of naïve CII-specific B cells, a substantial amount of the autoreactive cells are deleted in the periphery. However, peripheral B-cell tolerance is incomplete, as CII-specific B cells are enriched in the pool of memory B cells. Disclosure of Interest None declared

A Novel Hla-Drb1*10:01-Restricted T Cell Epitope from Citrullinated Type Ii Collagen Relevant to Rheumatoid Arthritis

[T Cell Proliferative Response and Antibody Formation to Citrullinated Collagen Type II in Patients with Rheumatoid Arthritis].

Multifunctional T Cell Reactivity to Native and Glycosylated Type-II Collagen in Rheumatoid Arthritis.

Structure and Pathogenicity of Antibodies Specific for Citrullinated Collagen Type Ii in Experimental Arthritis

Multiple Antibody Reactivities to Citrullinated Antigens in Sera from Patients with Rheumatoid Arthritis: Association with HLA-DRB1 Alleles

Humoral Immune Response to Citrullinated Collagen Type II Determinants in Early Rheumatoid Arthritis

Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen.

Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor

The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4

Predominant Selection of T Cells Specific for the Glycosylated Collagen Type II Epitope (263-270) in Humanized Transgenic Mice and in Rheumatoid Arthritis.

Definition of Mhc and T Cell Receptor Contacts in the Hla-Dr4-Restricted Immunodominant Epitope in Type Ii Collagen and Characterization of Collagen-Induced Arthritis in Hla-Dr4 and Human Cd4 Transgenic Mice

The Autoantibody Response to Cyclic Citrullinated Collagen Type II Peptides in Rheumatoid Arthritis.

The Impact of Glycosylation on Hla-Dr1-Restricted T Cell Recognition of Type Ii Collagen in A Mouse Model

[Significance of Citrullinated Collagen Type II and Its Antibodies in Rheumatoid Arthritis].

Citrullination of Collagen II Affects Integrin‐mediated Cell Adhesion in a Receptor‐specific Manner

SAT0031 Detection and Isolation of Antigen Specific B Cells in Patients with Rheumatoid Arthritis

Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides

Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage

Association Between Protein Tyrosine Phosphatase 22 Variant R620W in Conjunction with the HLA-DRB1 Shared Epitope and Humoral Autoimmunity to an Immunodominant Epitope of Cartilage-Specific Type II Collagen in Early Rheumatoid Arthritis.

Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis

Cartilage-Specific Autoimmunity in Rheumatoid Arthritis: Characterization of A Triple Helical B Cell Epitope in the Integrin-Binding-Domain of Collagen Type Ii